Skip to main content

Table 2 Gradational analysis of ORR and DCR

From: First-line single agent treatment with gefitinib in patients with advanced non-small-cell lung cancer

Characters ORR(%) P value DCR(%) P value
Gender     
   Male 13.3 0.033 52.6 0.019
   Female 40.0   84.6  
Age(year)     
   < 70 34.3 1.000 71.4 1.000
   ≥70 30.0   70.0  
Smoking status     
   Smokers 17.6 0.082 58.8 0.281
   Nonsmokers 42.9   78.6  
Tumor histology     
   Adeno. And BAC 43.3 0.044 83.3 0.027
   Non-adeno.    13.3   46.7  
Stage     
   IIIb 28.6 0.909 78.6 0.699
   IV 35.5   67.7  
PS value     
   ≤ 2 37.5 0.561 75.5 0.589
   3~4 23.1   61.5